Press Enter to search · ESC to close

US Stocks

Fosun Pharma Chairman Proposes RMB 250-500M A-Share Buyback

Fosun Pharma chairman Chen Yuqing has proposed a buyback of the company’s A-shares through centralized bidding, with total funds of no less than RMB 250 million and no more than RMB 500 million. The repurchase price would not exceed 150% of the average price over the 30 trading days before the board approves the plan. The buyback, valid for up to 12 months, would fund convertible bond conversion, equity incentives and/or employee stock ownership plans.

Share

Related News

Cointime share card
Long-press the image to save or share
Pitch us Community Feedback